06699.HK
Angelalign Technology Inc.
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 75.65
−1.30%Year over year
Reported trailing growth
- Revenue
- +37.2%
- EBITDA
- +179.2%
- EBIT
- +137.2%
- EPS
- +64.4%
- Free cash flow
- +274.9%
- Operating cash flow
- +111.0%
Forward estimates
Based on analyst estimates
- Revenue
- -25.3%
- EBITDA
- +45.5%
- EPS
- +90.3%
Three-year CAGR
- Revenue
- +26.9%
- EBITDA
- -2.7%
- EBIT
- -8.2%
- Net income
- -2.3%
- EPS
- -2.7%
- Free cash flow
- +116.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026